Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Medicale (MCLE) EPS (Weighted Average and Diluted) (2021 - 2025)

Historic EPS (Weighted Average and Diluted) for Medicale (MCLE) over the last 3 years, with Q2 2025 value amounting to -$0.0.

  • Medicale's EPS (Weighted Average and Diluted) changed N/A to -$0.0 in Q2 2025 from the same period last year, while for Jun 2025 it was -$0.0, marking a year-over-year change of. This contributed to the annual value of $0.0 for FY2023, which is 11895.83% up from last year.
  • As of Q2 2025, Medicale's EPS (Weighted Average and Diluted) stood at -$0.0.
  • In the past 5 years, Medicale's EPS (Weighted Average and Diluted) ranged from a high of $0.0 in Q4 2022 and a low of -$0.0 during Q3 2021
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$0.0 (2021), whereas its average is -$0.0.
  • Within the past 5 years, the most significant YoY rise in Medicale's EPS (Weighted Average and Diluted) was 17583.33% (2022), while the steepest drop was 9132.45% (2022).
  • Medicale's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.0 in 2021, then skyrocketed by 175.83% to $0.0 in 2022, then crashed by 885.71% to -$0.0 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.0 for Q2 2025, versus -$0.0 for Q1 2025 and $0.0 for Q4 2022.